Sanjivani Paranterals Ltd (BOM:531569)

Q3 2026 Sanjivani Paranteral Ltd Earnings Call Transcript

Feb 15, 2026 / 05:30 AM GMT

Release Date Price: ₹207.55 (-1.40%)

Transcript

Key Points

Positve

Sanjivani Paranterals Ltd (BOM:531569) reported a strong year-on-year revenue growth of approximately 20%, driven primarily by export markets and product mix improvements.
The Pune infusion facility began contributing to consolidated revenues for the first time, marking a significant milestone for the company.
The company recorded a 36% year-on-year growth in EBITA, with margins improving to 18.4% from 16.2% in the previous year.
The nutraceutical venture in Europe is gaining momentum, with increased customer engagement and a promising pipeline of potential business.
Sanjivani Paranterals Ltd (BOM:531569) is expanding its manufacturing footprint and diversifying revenue streams through strategic investments and joint ventures.

Negative

Injectable revenues declined by 9.7% year-on-year, indicating challenges in this segment.
The operating environment remains uncertain from a policy standpoint, with export-oriented businesses monitoring tariff developments and currency movements.
Pricing sensitivity and regulatory scrutiny continue to shape competitive dynamics, posing challenges for maintaining margins.
The Pune infusion facility is still in the early stages of ramp-up, with current capacity utilization at only 20-23%.
Logistical issues, particularly in African markets, have posed challenges, although they are reportedly being resolved.

Refinitiv StreetEvents Event Transcript
E D I T E D V E R S I O N

SANJ.BO - Sanjivani Paranteral Ltd
Q3 2026 Sanjivani Paranteral Ltd Earnings Call
Feb 16, 2026 / 05:30AM GMT

=====================
Presentation
--------------------------------------------------------------------------------
Unidentified_1 [1]
--------------------------------------------------------------------------------
And gentlemen, good day and welcome to the Sanjeevni Parental Limited Q3 F526 earnings conference call. From the Sanjeevni management we have with us Mr. Rashwini Kemka, Chairman and managing director, Mr. Shivadan Kemka, executive director, and Mr. Prash Jain, Chief Financial Officer.

We will begin with management's commentary, after which we will open the floor for questions. As a reminder, all participant lines will be in the listen-only mode, and there will be an opportunity for you to ask questions after the presentation concludes. Should you need assistance during this conference call, please signal an operator by pressing, then 0 on a touchstone phone. Please note that this conference is being recorded. I now

Already have an account? Log in

Get the full story

Subscribe Now

	Access to All Earning Calls and Stock Analysis
	30-Year Financial on one screen
	All-in-one Stock Screener with unlimited filters
	Customizable Stock Dashboard
	Real Time Insider Trading Transactions
	8,000+ Institutional investors’ 13F holdings
	Powerful Excel Add-in and Google sheets Add-on
	All data downloadable
	Quick customer support
	And much more...

7-Day Free Trial · Cancel Anytime

Subscription fee may be tax deductible.

Excellent

4.6 out of 5

Trustpilot

Research Tools

All-In-One Screener Stock Ideas Stock List Guru List Guru Real-Time Picks Insider List Insider Trades Economic Indicators Sector & Industry Performance DCF Calculator Calculators Discussion Board

Product

Pricing Plans Excel Add-In Google Sheets Add-on Data API Stock Comparison Table Manual of Stocks Instant Alerts Mobile App Newsletters Signup 中文

Education

Financial Glossary Tutorials FAQ Buffett Indicator Shiller P/E Yield Curve Today U.S. Inflation Rate Global Market Valuation Fed Net Liquidity Buffett Assets Allocation

Company

About GuruFocus Career Contact Us Advertise Term of Use Privacy Policy Referral Program Partner Program

Survey

We'd love to learn more about your experiences on GuruFocus.com and how we can improve!

Take Survey

Disclaimers

GuruFocus.com is not operated by a broker or a dealer. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes are provided by QuoteMedia, Inc. (CSI). Company fundamental data is provided by Morningstar. Analyst estimates data is sourced from both Refinitiv and Morningstar, with priority given to Refinitiv data. Data is updated daily.